SELECT LANGUAGE BELOW

Study suggests Eli Lilly’s weight-loss medication may reduce signals for binge eating.

Study suggests Eli Lilly's weight-loss medication may reduce signals for binge eating.

Researchers studying brain activity in patients with significant overeating issues found that Eli Lilly’s weight loss medicine, GLP-1, seems to temporarily reduce hunger signals in the brain’s “reward center.” This marks the first time direct brain activity measurements have been taken from individuals receiving tirzepatide—marketed as Mounjaro for diabetes and Zepbound for weight loss—which showcased […]